Osaic Holdings’s Telix Pharmaceuticals TLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.24K Buy
756
+442
+141% +$3.37K ﹤0.01% 6481
2025
Q4
$2.35K Sell
314
-22
-7% -$212 ﹤0.01% 7041
2025
Q3
$3.22K Buy
336
+291
+647% +$3.56K ﹤0.01% 6972
2025
Q2
$723 Buy
+45
New +$756 ﹤0.01% 7259

Other funds holding TLX

Osaic Holdings's TLX Position: Q1 2026 in Review

Osaic Holdings increased its Telix Pharmaceuticals (TLX) stake by 141% in Q1 2026, buying an estimated $3.37K and bringing the position to 756 shares worth $7.24K. The position accounts for ﹤0.01% of the portfolio, ranked #6481.

Osaic Holdings first reported a position in TLX in Q2 2025 and has held it in 4 quarters since. 39 funds tracked by Wall St. Rank hold TLX as of Q1 2026.

  • Osaic Holdings held 756 shares of Telix Pharmaceuticals worth $7.24K as of Q1 2026.
  • Osaic Holdings bought 442 Telix Pharmaceuticals shares in Q1 2026, an estimated $3.37K.
  • Telix Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6481 holding.
  • Osaic Holdings first reported a position in Telix Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 39 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.